These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 10496646)

  • 1. Assessment of value and applications of in vitro testing of topical dermatological drug products.
    Flynn GL; Shah VP; Tenjarla SN; Corbo M; DeMagistris D; Feldman TG; Franz TJ; Miran DR; Pearce DM; Sequeira JA; Swarbrick J; Wang JC; Yacobi A; Zatz JL
    Pharm Res; 1999 Sep; 16(9):1325-30. PubMed ID: 10496646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP.
    Burgess DJ; Hussain AS; Ingallinera TS; Chen ML
    Pharm Res; 2002 Nov; 19(11):1761-8. PubMed ID: 12458685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro - in vivo correlation: from theory to applications.
    Emami J
    J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Report of the AAPS Guidance Forum on the FDA Draft Guidance for Industry: "Drug Products, Including Biological Products, that Contain Nanomaterials".
    de Vlieger JSB; Crommelin DJA; Tyner K; Drummond DC; Jiang W; McNeil SE; Neervannan S; Crist RM; Shah VP
    AAPS J; 2019 Apr; 21(4):56. PubMed ID: 30997588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Workshop III Report: Scaleup of Liquid and Semisolid Disperse Systems. AAPS/FDA Committee.
    Van Buskirk GA; Shah VP; Adair D; Arbit HM; Dighe SV; Fawzi M; Feldman T; Flynn GL; Gonzalez MA; Gray VA
    PDA J Pharm Sci Technol; 1995; 49(3):145-9. PubMed ID: 7613993
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of in vitro release rates of acyclovir from cream formulations using vertical diffusion cells.
    Nallagundla S; Patnala S; Kanfer I
    AAPS PharmSciTech; 2014 Aug; 15(4):994-9. PubMed ID: 24824173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perspectives on Physicochemical and In Vitro Profiling of Ophthalmic Ointments.
    Bao Q; Burgess DJ
    Pharm Res; 2018 Oct; 35(12):234. PubMed ID: 30324424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparing for an FDA preapproval inspection.
    Blackmer RA
    Qual Assur; 1994 Dec; 3(4):389-403. PubMed ID: 7613749
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Kulkarni M; Potdar S; Date AA; Marfatiya A
    Assay Drug Dev Technol; 2021; 19(2):75-84. PubMed ID: 33035072
    [No Abstract]   [Full Text] [Related]  

  • 10. Development in release testing of topical dosage forms: use of the Enhancer Cell with automated sampling.
    Rege PR; Vilivalam VD; Collins CC
    J Pharm Biomed Anal; 1998 Sep; 17(8):1226-33. PubMed ID: 9800641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro release test (IVRT): Principles and applications.
    Shah VP; Simona Miron D; Ștefan Rădulescu F; Cardot JM; Maibach HI
    Int J Pharm; 2022 Oct; 626():122159. PubMed ID: 36067919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cautious welcome for FDA pharmacogenomics guidance.
    Katsnelson A;
    Nat Biotechnol; 2005 May; 23(5):510. PubMed ID: 15877053
    [No Abstract]   [Full Text] [Related]  

  • 13. A review of the FDA draft guidance document for software validation: guidance for industry.
    Keatley KL
    Qual Assur; 1999; 7(1):49-55. PubMed ID: 10707376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data Integrity: History, Issues, and Remediation of Issues.
    Rattan AK
    PDA J Pharm Sci Technol; 2018; 72(2):105-116. PubMed ID: 29158286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Clobetasol Propionate Generics Using Simplified In vitro Bioequivalence Method for Topical Drug Products.
    Soares KCC; de Souza WC; de S Texeira L; da Cunha-Filho MSS; Gelfuso GM; Gratieri T
    Curr Drug Deliv; 2018; 15(7):998-1008. PubMed ID: 29165079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the test system used for in vitro release of drugs for topical dermatological drug products.
    Shah VP; Elkins JS; Williams RL
    Pharm Dev Technol; 1999 Aug; 4(3):377-85. PubMed ID: 10434283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Conference on Harmonisation; S10 Photosafety Evaluation of Pharmaceuticals; guidance for industry; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2015 Jan; 80(17):4282-3. PubMed ID: 25730921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the US FDA "Biopharmaceutics Classification System" (BCS) Guidance on Global Drug Development.
    Mehta MU; Uppoor RS; Conner DP; Seo P; Vaidyanathan J; Volpe DA; Stier E; Chilukuri D; Dorantes A; Ghosh T; Mandula H; Raines K; Dhanormchitphong P; Woodcock J; Yu LX
    Mol Pharm; 2017 Dec; 14(12):4334-4338. PubMed ID: 29076742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging prior quantitative knowledge to guide drug development decisions and regulatory science recommendations: impact of FDA pharmacometrics during 2004-2006.
    Wang Y; Bhattaram AV; Jadhav PR; Lesko LJ; Madabushi R; Powell JR; Qiu W; Sun H; Yim DS; Zheng JJ; Gobburu JV
    J Clin Pharmacol; 2008 Feb; 48(2):146-56. PubMed ID: 18199891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate specifications at the IND stage.
    Geigert J
    Dev Biol Stand; 1997; 91():39-43. PubMed ID: 9413681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.